Demystifying and Realizing the Potential of Drug, Device, and Diagnostic Convergence
Tuesday, January 15
2:00 PM EST (19:00 GMT)
1 CPE Credit: Business Management & Organization*

Is the convergence of drugs, devices, and diagnostics leading to innovative health solutions, new opportunities for business growth, and product differentiation in the life sciences industry? We'll discuss:

• Major challenges involved in selecting and managing a pathway to convergence, including investment risks, regulatory uncertainties, and issues related to partnerships and alliance networks.
• Frameworks for evaluating investment options, defining a convergence approach, and partnering effectively.
• Leading practices for making collaboration work at individual and organizational levels.

Learn key challenges in the development of combination products and how to address potential pitfalls to achieve the potential of convergence.